17 September 2019PatentsIain Armstrong

Immunotherapy patents: Why CAR-T is driving up patent activity

Immunotherapies are a hugely promising therapeutic area, in terms of both clinical benefits and potential market size. These treatments augment the body’s own immune response to improve its effectiveness in fighting diseases, particularly cancer.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

UPC docs 'excessively redacted' under GDPR claims transparency lawyer

L'Oréal sued over virtual makeup try-on simulator

Kathi Vidal to leave USPTO ahead of incoming Trump administration

Q&A: EagleView counsel maps out route to IPR victory

WIPO in Saudi Arabia to finalise design law treaty

Douwe Egberts enjoys double shot over Nestlé in coffee patent rivalry

Startup CFO’s betrayal is a lesson in preparing for the worst

President Trump 2.0: Five major areas to watch

Immunotherapy patents: Why CAR-T is driving up patent activity

More on this story

Editor's picks

Editor's picks

More articles